UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-21667
Fidelity Central Investment Portfolios LLC
(Exact name of registrant as specified in charter)
245 Summer St., Boston, Massachusetts 02210
(Address of principal executive offices) (Zip code)
Margaret Carey, Secretary
245 Summer St.
Boston, Massachusetts 02210
(Name and address of agent for service)
Registrant's telephone number, including area code:
617-563-7000
Date of fiscal year end: | June 30 |
Date of reporting period: | June 30, 2023 |
Item 1.
Reports to Stockholders
Contents
Average Annual Total Returns | |||
Periods ended June 30, 2023 | Past 1 year | Life of Fund A |
Fidelity® U.S. Equity Central Fund | 20.95% | 12.00% |
$10,000 Over Life of Fund |
Let's say hypothetically that $10,000 was invested in Fidelity® U.S. Equity Central Fund, on September 18, 2020, when the fund started. The chart shows how the value of your investment would have changed, and also shows how the MSCI U.S. Investable Market 2500 Index performed over the same period. |
Top Holdings (% of Fund's net assets) | ||
Microsoft Corp. | 6.9 | |
Apple, Inc. | 5.8 | |
Alphabet, Inc. Class A | 3.5 | |
Amazon.com, Inc. | 3.1 | |
Exxon Mobil Corp. | 1.8 | |
Meta Platforms, Inc. Class A | 1.7 | |
JPMorgan Chase & Co. | 1.5 | |
NVIDIA Corp. | 1.5 | |
Tesla, Inc. | 1.4 | |
Visa, Inc. Class A | 1.3 | |
28.5 | ||
Market Sectors (% of Fund's net assets) | ||
Information Technology | 25.1 | |
Health Care | 13.0 | |
Financials | 12.6 | |
Consumer Discretionary | 10.5 | |
Industrials | 10.2 | |
Communication Services | 8.5 | |
Consumer Staples | 6.7 | |
Energy | 4.2 | |
Real Estate | 2.9 | |
Materials | 2.7 | |
Utilities | 2.5 | |
Asset Allocation (% of Fund's net assets) |
Futures - 0.2% |
Common Stocks - 98.4% | |||
Shares | Value ($) | ||
COMMUNICATION SERVICES - 8.4% | |||
Diversified Telecommunication Services - 0.1% | |||
AT&T, Inc. | 89,800 | 1,432,310 | |
Liberty Global PLC Class C (a) | 592,218 | 10,523,714 | |
11,956,024 | |||
Entertainment - 1.8% | |||
Activision Blizzard, Inc. | 353,825 | 29,827,448 | |
Cinemark Holdings, Inc. (a)(b) | 441,500 | 7,284,750 | |
Electronic Arts, Inc. | 305,196 | 39,583,921 | |
Endeavor Group Holdings, Inc. (a) | 123,100 | 2,944,552 | |
Lions Gate Entertainment Corp.: | |||
Class A (a)(b) | 89,400 | 789,402 | |
Class B (a) | 483,026 | 4,033,267 | |
Marcus Corp. (b) | 344,000 | 5,101,520 | |
Netflix, Inc. (a) | 260,605 | 114,793,896 | |
Sea Ltd. ADR (a) | 143,500 | 8,328,740 | |
Take-Two Interactive Software, Inc. (a) | 143,860 | 21,170,438 | |
The Walt Disney Co. (a) | 491,020 | 43,838,266 | |
Warner Music Group Corp. Class A | 188,000 | 4,904,920 | |
World Wrestling Entertainment, Inc. Class A (b) | 207,412 | 22,497,980 | |
305,099,100 | |||
Interactive Media & Services - 5.4% | |||
Alphabet, Inc. Class A (a) | 4,946,400 | 592,084,080 | |
Angi, Inc. (a) | 1,155,332 | 3,812,596 | |
IAC, Inc. (a) | 15,000 | 942,000 | |
Meta Platforms, Inc. Class A (a) | 965,525 | 277,086,365 | |
Pinterest, Inc. Class A (a) | 460,200 | 12,581,868 | |
Shutterstock, Inc. | 7,700 | 374,759 | |
Snap, Inc. Class A (a) | 1,547,800 | 18,325,952 | |
Zoominfo Technologies, Inc. (a) | 118,000 | 2,996,020 | |
908,203,640 | |||
Media - 0.7% | |||
Advantage Solutions, Inc. Class A (a) | 429,700 | 1,005,498 | |
Altice U.S.A., Inc. Class A (a) | 715,600 | 2,161,112 | |
Comcast Corp. Class A | 1,488,482 | 61,846,427 | |
DISH Network Corp. Class A (a)(b) | 77,263 | 509,163 | |
Liberty Broadband Corp.: | |||
Class A (a) | 294,831 | 23,506,876 | |
Class C (a) | 241,800 | 19,370,598 | |
S4 Capital PLC (a) | 692,100 | 1,107,498 | |
TechTarget, Inc. (a) | 25,500 | 793,815 | |
110,300,987 | |||
Wireless Telecommunication Services - 0.4% | |||
T-Mobile U.S., Inc. (a) | 463,538 | 64,385,428 | |
TOTAL COMMUNICATION SERVICES | 1,399,945,179 | ||
CONSUMER DISCRETIONARY - 10.5% | |||
Automobile Components - 0.2% | |||
Adient PLC (a) | 271,745 | 10,413,268 | |
Aptiv PLC (a) | 137,100 | 13,996,539 | |
24,409,807 | |||
Automobiles - 1.5% | |||
Ferrari NV | 41,991 | 13,655,893 | |
Tesla, Inc. (a) | 899,110 | 235,360,025 | |
249,015,918 | |||
Broadline Retail - 3.4% | |||
Amazon.com, Inc. (a) | 4,014,568 | 523,339,084 | |
eBay, Inc. | 778,216 | 34,778,473 | |
Ollie's Bargain Outlet Holdings, Inc. (a) | 225,459 | 13,060,840 | |
571,178,397 | |||
Hotels, Restaurants & Leisure - 2.3% | |||
ARAMARK Holdings Corp. | 642,594 | 27,663,672 | |
Booking Holdings, Inc. (a) | 24,123 | 65,140,061 | |
Caesars Entertainment, Inc. (a) | 427,358 | 21,782,437 | |
Churchill Downs, Inc. | 287,364 | 39,992,448 | |
Domino's Pizza, Inc. | 84,319 | 28,414,660 | |
Hilton Worldwide Holdings, Inc. | 293,003 | 42,646,587 | |
Marriott International, Inc. Class A | 266,576 | 48,967,345 | |
McDonald's Corp. | 115,690 | 34,523,053 | |
Penn Entertainment, Inc. (a) | 270,500 | 6,500,115 | |
Planet Fitness, Inc. (a)(b) | 182,407 | 12,301,528 | |
Red Rock Resorts, Inc. | 230,800 | 10,796,824 | |
Yum! Brands, Inc. | 339,600 | 47,051,580 | |
385,780,310 | |||
Household Durables - 0.2% | |||
D.R. Horton, Inc. | 135,120 | 16,442,753 | |
Helen of Troy Ltd. (a) | 31,900 | 3,445,838 | |
Mohawk Industries, Inc. (a) | 103,557 | 10,682,940 | |
Newell Brands, Inc. | 39,200 | 341,040 | |
30,912,571 | |||
Specialty Retail - 1.9% | |||
Fast Retailing Co. Ltd. | 40,400 | 10,361,582 | |
Five Below, Inc. (a) | 113,029 | 22,214,720 | |
Lowe's Companies, Inc. | 494,361 | 111,577,278 | |
The Home Depot, Inc. | 159,234 | 49,464,450 | |
TJX Companies, Inc. | 1,265,776 | 107,325,147 | |
Valvoline, Inc. | 500,471 | 18,772,667 | |
319,715,844 | |||
Textiles, Apparel & Luxury Goods - 1.0% | |||
Capri Holdings Ltd. (a) | 338,836 | 12,160,824 | |
lululemon athletica, Inc. (a) | 125,567 | 47,527,110 | |
LVMH Moet Hennessy Louis Vuitton SE | 13,291 | 12,532,247 | |
NIKE, Inc. Class B | 343,110 | 37,869,051 | |
PVH Corp. | 381,221 | 32,392,348 | |
Tapestry, Inc. | 616,561 | 26,388,811 | |
168,870,391 | |||
TOTAL CONSUMER DISCRETIONARY | 1,749,883,238 | ||
CONSUMER STAPLES - 6.7% | |||
Beverages - 2.2% | |||
Boston Beer Co., Inc. Class A (a) | 97,550 | 30,088,322 | |
Brown-Forman Corp. Class B (non-vtg.) | 10,800 | 721,224 | |
Constellation Brands, Inc. Class A (sub. vtg.) | 136,366 | 33,563,764 | |
Diageo PLC | 232,613 | 10,000,266 | |
Keurig Dr. Pepper, Inc. | 2,025,401 | 63,334,289 | |
Monster Beverage Corp. | 626,756 | 36,000,865 | |
PepsiCo, Inc. | 207,700 | 38,470,194 | |
Primo Water Corp. | 331,300 | 4,154,502 | |
The Coca-Cola Co. | 2,450,091 | 147,544,480 | |
363,877,906 | |||
Consumer Staples Distribution & Retail - 1.5% | |||
Albertsons Companies, Inc. | 350,600 | 7,650,092 | |
Alimentation Couche-Tard, Inc. Class A (multi-vtg.) | 306,700 | 15,726,840 | |
BJ's Wholesale Club Holdings, Inc. (a) | 215,800 | 13,597,558 | |
Costco Wholesale Corp. | 900 | 484,542 | |
Dollar General Corp. | 165,169 | 28,042,393 | |
Dollar Tree, Inc. (a) | 150,300 | 21,568,050 | |
Grocery Outlet Holding Corp. (a) | 21,600 | 661,176 | |
Kroger Co. | 28,900 | 1,358,300 | |
Performance Food Group Co. (a) | 613,702 | 36,969,408 | |
Sysco Corp. | 149,800 | 11,115,160 | |
Target Corp. | 211,600 | 27,910,040 | |
U.S. Foods Holding Corp. (a) | 78,908 | 3,471,952 | |
United Natural Foods, Inc. (a) | 3,700 | 72,335 | |
Walgreens Boots Alliance, Inc. | 38,400 | 1,094,016 | |
Walmart, Inc. | 515,600 | 81,042,008 | |
250,763,870 | |||
Food Products - 0.9% | |||
Archer Daniels Midland Co. | 107,700 | 8,137,812 | |
Bunge Ltd. | 156,300 | 14,746,905 | |
Conagra Brands, Inc. | 199,700 | 6,733,884 | |
Darling Ingredients, Inc. (a) | 108,226 | 6,903,737 | |
Freshpet, Inc. (a) | 178,400 | 11,740,504 | |
General Mills, Inc. | 38,200 | 2,929,940 | |
Ingredion, Inc. | 4,600 | 487,370 | |
Laird Superfood, Inc. (a) | 119,100 | 94,690 | |
Mondelez International, Inc. | 772,512 | 56,347,025 | |
Nomad Foods Ltd. (a) | 1,116,000 | 19,552,320 | |
Pilgrim's Pride Corp. (a) | 9,000 | 193,410 | |
The Hain Celestial Group, Inc. (a) | 41,500 | 519,165 | |
The J.M. Smucker Co. | 7,700 | 1,137,059 | |
The Kraft Heinz Co. | 6,400 | 227,200 | |
The Real Good Food Co. LLC: | |||
Class B (a)(c) | 155,856 | 2 | |
Class B unit (a)(d) | 155,856 | 540,820 | |
The Real Good Food Co., Inc. (a) | 300 | 1,041 | |
The Simply Good Foods Co. (a) | 81,600 | 2,985,744 | |
TreeHouse Foods, Inc. (a) | 38,703 | 1,949,857 | |
Tyson Foods, Inc. Class A | 219,400 | 11,198,176 | |
146,426,661 | |||
Household Products - 1.3% | |||
Colgate-Palmolive Co. | 57,800 | 4,452,912 | |
Energizer Holdings, Inc. | 636,815 | 21,384,248 | |
Kimberly-Clark Corp. | 117,800 | 16,263,468 | |
Procter & Gamble Co. | 1,061,593 | 161,086,122 | |
Reynolds Consumer Products, Inc. | 283,226 | 8,001,135 | |
Spectrum Brands Holdings, Inc. (b) | 56,000 | 4,370,800 | |
The Clorox Co. | 22,700 | 3,610,208 | |
219,168,893 | |||
Personal Care Products - 0.2% | |||
Estee Lauder Companies, Inc. Class A | 65,700 | 12,902,166 | |
Herbalife Ltd. (a) | 423,613 | 5,608,636 | |
Olaplex Holdings, Inc. (a) | 1,992,900 | 7,413,588 | |
The Beauty Health Co. (a) | 44,000 | 368,280 | |
The Beauty Health Co. (a)(e) | 600,000 | 5,022,000 | |
31,314,670 | |||
Tobacco - 0.6% | |||
Altria Group, Inc. | 1,054,667 | 47,776,415 | |
Philip Morris International, Inc. | 598,453 | 58,420,982 | |
106,197,397 | |||
TOTAL CONSUMER STAPLES | 1,117,749,397 | ||
ENERGY - 4.2% | |||
Energy Equipment & Services - 0.6% | |||
Core Laboratories, Inc. | 80,700 | 1,876,275 | |
Diamond Offshore Drilling, Inc. (a) | 167,800 | 2,389,472 | |
Expro Group Holdings NV (a) | 1,053,300 | 18,664,476 | |
Noble Corp. PLC | 59,000 | 2,437,290 | |
Schlumberger Ltd. | 507,600 | 24,933,312 | |
TechnipFMC PLC (a) | 875,200 | 14,545,824 | |
Valaris Ltd. (a) | 72,300 | 4,549,839 | |
Weatherford International PLC (a) | 490,800 | 32,598,936 | |
101,995,424 | |||
Oil, Gas & Consumable Fuels - 3.6% | |||
Africa Oil Corp. | 6,537,700 | 13,916,825 | |
Athabasca Oil Corp. (a) | 380,900 | 825,199 | |
Canadian Natural Resources Ltd. | 531,759 | 29,896,517 | |
Cheniere Energy, Inc. | 30,000 | 4,570,800 | |
Eco Atlantic Oil & Gas Ltd. (a) | 4,861,000 | 825,609 | |
Exxon Mobil Corp. | 2,739,538 | 293,815,451 | |
Hess Corp. | 451,975 | 61,446,001 | |
Imperial Oil Ltd. | 1,031,200 | 52,760,699 | |
Kosmos Energy Ltd. (a) | 2,777,673 | 16,638,261 | |
MEG Energy Corp. (a) | 2,455,550 | 38,925,495 | |
PBF Energy, Inc. Class A | 110,900 | 4,540,246 | |
Phillips 66 Co. | 324,959 | 30,994,589 | |
Tourmaline Oil Corp. | 124,800 | 5,880,367 | |
Valero Energy Corp. | 331,286 | 38,859,848 | |
593,895,907 | |||
TOTAL ENERGY | 695,891,331 | ||
FINANCIALS - 12.4% | |||
Banks - 5.1% | |||
AIB Group PLC | 1,494,840 | 6,280,002 | |
Bank of America Corp. | 4,830,454 | 138,585,725 | |
Bank of Ireland Group PLC | 2,348,400 | 22,391,772 | |
BNP Paribas SA | 430,903 | 27,192,546 | |
Citigroup, Inc. | 796,739 | 36,681,864 | |
DNB Bank ASA | 773,000 | 14,455,648 | |
JPMorgan Chase & Co. | 1,772,269 | 257,758,803 | |
KBC Group NV | 189,200 | 13,196,606 | |
KeyCorp | 1,838,700 | 16,989,588 | |
M&T Bank Corp. | 202,249 | 25,030,336 | |
NatWest Group PLC | 4,592,606 | 14,037,261 | |
Piraeus Financial Holdings SA (a) | 3,343,502 | 10,967,179 | |
PNC Financial Services Group, Inc. | 211,900 | 26,688,805 | |
Popular, Inc. | 442,500 | 26,780,100 | |
Starling Bank Ltd. Series D (a)(c)(e) | 4,618,325 | 17,126,597 | |
Sumitomo Mitsui Financial Group, Inc. | 374,600 | 16,055,149 | |
U.S. Bancorp | 536,916 | 17,739,705 | |
UniCredit SpA | 1,181,737 | 27,479,610 | |
Wells Fargo & Co. | 2,746,271 | 117,210,846 | |
Zions Bancorp NA | 405,700 | 10,897,102 | |
843,545,244 | |||
Capital Markets - 1.2% | |||
Bank of New York Mellon Corp. | 1,805,575 | 80,384,199 | |
BlackRock, Inc. Class A | 10,816 | 7,475,370 | |
Brookfield Corp. Class A | 291,739 | 9,817,017 | |
Cboe Global Markets, Inc. | 170,630 | 23,548,646 | |
Patria Investments Ltd. | 898,838 | 12,853,383 | |
State Street Corp. | 455,100 | 33,304,218 | |
StepStone Group, Inc. Class A | 343,672 | 8,526,502 | |
UBS Group AG | 1,174,500 | 23,807,115 | |
Virtu Financial, Inc. Class A | 434,424 | 7,424,306 | |
207,140,756 | |||
Consumer Finance - 0.2% | |||
Capital One Financial Corp. | 60,935 | 6,664,461 | |
NerdWallet, Inc. (a) | 193,200 | 1,818,012 | |
OneMain Holdings, Inc. | 569,304 | 24,872,892 | |
33,355,365 | |||
Financial Services - 2.9% | |||
Ant International Co. Ltd. Class C (a)(c)(e) | 5,601,170 | 8,457,767 | |
Apollo Global Management, Inc. | 531,162 | 40,798,553 | |
Block, Inc. Class A (a) | 379,100 | 25,236,687 | |
Essent Group Ltd. | 499,933 | 23,396,864 | |
Fiserv, Inc. (a) | 526,400 | 66,405,360 | |
Global Payments, Inc. | 221,700 | 21,841,884 | |
Jumo World Ltd. (a)(c) | 998 | 953,240 | |
MGIC Investment Corp. | 790,819 | 12,487,032 | |
Mr. Cooper Group, Inc. (a) | 20 | 1,013 | |
Repay Holdings Corp. (a) | 1,047,644 | 8,203,053 | |
Shift4 Payments, Inc. (a) | 207,117 | 14,065,315 | |
UWM Holdings Corp. Class A (b) | 1,699,603 | 9,517,777 | |
Visa, Inc. Class A | 911,300 | 216,415,524 | |
Voya Financial, Inc. | 329,800 | 23,649,958 | |
Worldline SA (a)(d) | 314,265 | 11,488,020 | |
482,918,047 | |||
Insurance - 3.0% | |||
Arthur J. Gallagher & Co. | 119,658 | 26,273,307 | |
Beazley PLC | 2,184,767 | 16,342,713 | |
Chubb Ltd. | 491,767 | 94,694,654 | |
Direct Line Insurance Group PLC | 4,577,028 | 7,902,536 | |
Fairfax Financial Holdings Ltd. (sub. vtg.) | 26,301 | 19,700,486 | |
Globe Life, Inc. | 212,405 | 23,283,836 | |
Hartford Financial Services Group, Inc. | 652,933 | 47,024,235 | |
Marsh & McLennan Companies, Inc. | 242,739 | 45,654,351 | |
Progressive Corp. | 420,723 | 55,691,104 | |
Prudential PLC | 838,302 | 11,839,670 | |
Reinsurance Group of America, Inc. | 147,200 | 20,415,168 | |
The Travelers Companies, Inc. | 595,017 | 103,330,652 | |
Unum Group | 746,181 | 35,592,834 | |
507,745,546 | |||
TOTAL FINANCIALS | 2,074,704,958 | ||
HEALTH CARE - 12.8% | |||
Biotechnology - 2.4% | |||
Acelyrin, Inc. | 280,000 | 5,852,000 | |
Akero Therapeutics, Inc. (a) | 275,000 | 12,839,750 | |
Allogene Therapeutics, Inc. (a) | 1,000,000 | 4,970,000 | |
Alnylam Pharmaceuticals, Inc. (a) | 32,500 | 6,173,050 | |
Ambrx Biopharma, Inc. ADR (a) | 148,700 | 2,447,602 | |
Apellis Pharmaceuticals, Inc. (a) | 154,000 | 14,029,400 | |
Arcellx, Inc. (a) | 128,000 | 4,047,360 | |
Arcus Biosciences, Inc. (a) | 135,000 | 2,741,850 | |
Arcutis Biotherapeutics, Inc. (a) | 300,000 | 2,859,000 | |
Argenx SE ADR (a) | 120,000 | 46,767,600 | |
Ascendis Pharma A/S sponsored ADR (a) | 240,000 | 21,420,000 | |
Avidity Biosciences, Inc. (a) | 360,000 | 3,992,400 | |
Beam Therapeutics, Inc. (a) | 100,000 | 3,193,000 | |
Blueprint Medicines Corp. (a) | 167,000 | 10,554,400 | |
Caris Life Sciences, Inc. (c)(e) | 227,063 | 1,271,553 | |
Celldex Therapeutics, Inc. (a) | 200,000 | 6,786,000 | |
Cerevel Therapeutics Holdings (a) | 415,000 | 13,192,850 | |
Cytokinetics, Inc. (a) | 385,000 | 12,558,700 | |
Generation Bio Co. (a) | 240,000 | 1,320,000 | |
Janux Therapeutics, Inc. (a) | 160,000 | 1,899,200 | |
Karuna Therapeutics, Inc. (a) | 75,000 | 16,263,750 | |
Keros Therapeutics, Inc. (a) | 160,000 | 6,428,800 | |
Legend Biotech Corp. ADR (a) | 435,000 | 30,028,050 | |
Morphic Holding, Inc. (a) | 100,000 | 5,733,000 | |
Nuvalent, Inc. Class A (a) | 165,000 | 6,958,050 | |
Poseida Therapeutics, Inc. (a) | 800,000 | 1,408,000 | |
PTC Therapeutics, Inc. (a) | 145,000 | 5,897,150 | |
Regeneron Pharmaceuticals, Inc. (a) | 86,500 | 62,153,710 | |
Repligen Corp. (a) | 110,000 | 15,560,600 | |
Sarepta Therapeutics, Inc. (a) | 60,000 | 6,871,200 | |
Shattuck Labs, Inc. (a) | 280,000 | 873,600 | |
uniQure B.V. (a) | 180,000 | 2,062,800 | |
Vaxcyte, Inc. (a) | 325,000 | 16,230,500 | |
Vera Therapeutics, Inc. (a) | 280,000 | 4,494,000 | |
Vertex Pharmaceuticals, Inc. (a) | 24,000 | 8,445,840 | |
Xencor, Inc. (a) | 360,000 | 8,989,200 | |
Xenon Pharmaceuticals, Inc. (a) | 200,000 | 7,700,000 | |
Zentalis Pharmaceuticals, Inc. (a) | 340,000 | 9,591,400 | |
394,605,365 | |||
Health Care Equipment & Supplies - 2.7% | |||
Boston Scientific Corp. (a) | 2,760,000 | 149,288,400 | |
Insulet Corp. (a) | 160,000 | 46,134,400 | |
Intuitive Surgical, Inc. (a) | 50,000 | 17,097,000 | |
iRhythm Technologies, Inc. (a) | 100,000 | 10,432,000 | |
Masimo Corp. (a) | 356,000 | 58,579,800 | |
Nevro Corp. (a) | 70,000 | 1,779,400 | |
Novocure Ltd. (a) | 142,000 | 5,893,000 | |
Outset Medical, Inc. (a) | 240,000 | 5,248,800 | |
Penumbra, Inc. (a) | 290,000 | 99,777,400 | |
PROCEPT BioRobotics Corp. (a) | 170,000 | 6,009,500 | |
ResMed, Inc. | 145,000 | 31,682,500 | |
Stryker Corp. | 70,000 | 21,356,300 | |
Tandem Diabetes Care, Inc. (a) | 130,000 | 3,190,200 | |
456,468,700 | |||
Health Care Providers & Services - 3.5% | |||
Acadia Healthcare Co., Inc. (a) | 250,000 | 19,910,000 | |
agilon health, Inc. (a) | 2,800,000 | 48,552,000 | |
Alignment Healthcare, Inc. (a) | 1,000,000 | 5,750,000 | |
Centene Corp. (a) | 810,000 | 54,634,500 | |
Cigna Group | 235,000 | 65,941,000 | |
CVS Health Corp. | 350,000 | 24,195,500 | |
Elevance Health, Inc. | 35,000 | 15,550,150 | |
Humana, Inc. | 102,200 | 45,696,686 | |
LifeStance Health Group, Inc. (a) | 1,350,000 | 12,325,500 | |
Molina Healthcare, Inc. (a) | 32,500 | 9,790,300 | |
Privia Health Group, Inc. (a) | 820,000 | 21,410,200 | |
Surgery Partners, Inc. (a) | 1,000,000 | 44,990,000 | |
UnitedHealth Group, Inc. | 450,000 | 216,288,000 | |
585,033,836 | |||
Health Care Technology - 0.3% | |||
Doximity, Inc. (a)(b) | 175,000 | 5,953,500 | |
Evolent Health, Inc. (e) | 500,000 | 14,392,500 | |
Evolent Health, Inc. (a) | 80,000 | 2,424,000 | |
Phreesia, Inc. (a) | 280,000 | 8,682,800 | |
Veeva Systems, Inc. Class A (a) | 60,000 | 11,863,800 | |
43,316,600 | |||
Life Sciences Tools & Services - 2.1% | |||
10X Genomics, Inc. (a) | 440,000 | 24,569,600 | |
Bruker Corp. | 280,000 | 20,697,600 | |
Danaher Corp. | 536,000 | 128,640,000 | |
Eden Biologics, Inc. (a)(c) | 1,008,062 | 0 | |
IQVIA Holdings, Inc. (a) | 146,000 | 32,816,420 | |
Lonza Group AG | 18,500 | 11,024,971 | |
Olink Holding AB ADR (a) | 375,000 | 7,031,250 | |
Sartorius Stedim Biotech | 46,000 | 11,479,642 | |
Thermo Fisher Scientific, Inc. | 196,000 | 102,263,000 | |
West Pharmaceutical Services, Inc. | 48,500 | 18,549,795 | |
357,072,278 | |||
Pharmaceuticals - 1.8% | |||
Arvinas Holding Co. LLC (a) | 180,000 | 4,467,600 | |
AstraZeneca PLC (United Kingdom) | 370,000 | 53,041,083 | |
Chime Biologics Wuhan Co. Ltd. (a)(c) | 1,008,062 | 525,029 | |
Eli Lilly & Co. | 265,000 | 124,279,700 | |
Enliven Therapeutics, Inc. (a) | 100,000 | 2,041,000 | |
Merck & Co., Inc. | 365,000 | 42,117,350 | |
Novo Nordisk A/S Series B | 135,000 | 21,807,879 | |
Pharvaris BV (a) | 208,000 | 3,267,680 | |
Royalty Pharma PLC | 900,000 | 27,666,000 | |
UCB SA | 145,000 | 12,847,789 | |
Ventyx Biosciences, Inc. (a) | 200,632 | 6,580,730 | |
Verona Pharma PLC ADR (a) | 150,000 | 3,171,000 | |
301,812,840 | |||
TOTAL HEALTH CARE | 2,138,309,619 | ||
INDUSTRIALS - 10.2% | |||
Aerospace & Defense - 2.2% | |||
Axon Enterprise, Inc. (a) | 71,700 | 13,990,104 | |
HEICO Corp. Class A | 101,261 | 14,237,297 | |
Howmet Aerospace, Inc. | 528,000 | 26,167,680 | |
L3Harris Technologies, Inc. | 184,310 | 36,082,369 | |
Lockheed Martin Corp. | 164,300 | 75,640,434 | |
Northrop Grumman Corp. | 63,600 | 28,988,880 | |
Raytheon Technologies Corp. (b) | 636,798 | 62,380,732 | |
The Boeing Co. (a) | 498,700 | 105,305,492 | |
362,792,988 | |||
Building Products - 0.7% | |||
Carlisle Companies, Inc. | 172,778 | 44,322,740 | |
Trane Technologies PLC | 401,310 | 76,754,551 | |
121,077,291 | |||
Commercial Services & Supplies - 0.7% | |||
Cintas Corp. | 129,128 | 64,186,946 | |
The GEO Group, Inc. (a) | 487,500 | 3,490,500 | |
Waste Connections, Inc. (United States) | 391,072 | 55,895,921 | |
123,573,367 | |||
Construction & Engineering - 0.5% | |||
Willscot Mobile Mini Holdings (a) | 1,665,600 | 79,599,024 | |
Electrical Equipment - 1.0% | |||
AMETEK, Inc. | 729,232 | 118,048,076 | |
Eaton Corp. PLC | 95,000 | 19,104,500 | |
Nextracker, Inc. Class A (b) | 69,800 | 2,778,738 | |
Regal Rexnord Corp. | 158,000 | 24,316,200 | |
164,247,514 | |||
Ground Transportation - 1.4% | |||
CSX Corp. | 2,187,278 | 74,586,180 | |
Landstar System, Inc. | 270,885 | 52,156,198 | |
Old Dominion Freight Lines, Inc. | 80,583 | 29,795,564 | |
Uber Technologies, Inc. (a) | 716,300 | 30,922,671 | |
Union Pacific Corp. | 245,416 | 50,217,022 | |
237,677,635 | |||
Industrial Conglomerates - 0.2% | |||
Honeywell International, Inc. | 134,213 | 27,849,198 | |
Machinery - 2.7% | |||
AGCO Corp. | 307,600 | 40,424,792 | |
Caterpillar, Inc. | 433,583 | 106,683,097 | |
Chart Industries, Inc. (a) | 109,700 | 17,528,963 | |
Deere & Co. | 174,700 | 70,786,693 | |
Flowserve Corp. | 1,273,300 | 47,303,095 | |
Fortive Corp. | 1,388,894 | 103,847,604 | |
IDEX Corp. | 202,371 | 43,562,381 | |
ITT, Inc. | 275,300 | 25,660,713 | |
455,797,338 | |||
Marine Transportation - 0.1% | |||
Eagle Bulk Shipping, Inc. (b) | 121,200 | 5,822,448 | |
Genco Shipping & Trading Ltd. (b) | 256,400 | 3,597,292 | |
9,419,740 | |||
Passenger Airlines - 0.4% | |||
Delta Air Lines, Inc. | 973,600 | 46,284,944 | |
JetBlue Airways Corp. (a) | 2,108,800 | 18,683,968 | |
64,968,912 | |||
Professional Services - 0.3% | |||
Ceridian HCM Holding, Inc. (a) | 356,600 | 23,881,502 | |
ExlService Holdings, Inc. (a) | 34,666 | 5,236,646 | |
TransUnion Holding Co., Inc. | 338,295 | 26,498,647 | |
55,616,795 | |||
Trading Companies & Distributors - 0.0% | |||
Air Lease Corp. Class A | 129,800 | 5,432,130 | |
TOTAL INDUSTRIALS | 1,708,051,932 | ||
INFORMATION TECHNOLOGY - 25.1% | |||
Electronic Equipment, Instruments & Components - 0.5% | |||
Cognex Corp. | 205,522 | 11,513,342 | |
Corning, Inc. | 924,777 | 32,404,186 | |
TE Connectivity Ltd. | 247,541 | 34,695,347 | |
78,612,875 | |||
IT Services - 2.1% | |||
Akamai Technologies, Inc. (a) | 363,705 | 32,686,168 | |
Capgemini SA | 301,217 | 57,033,196 | |
Cognizant Technology Solutions Corp. Class A | 1,001,477 | 65,376,419 | |
EPAM Systems, Inc. (a) | 108,500 | 24,385,375 | |
GoDaddy, Inc. (a) | 502,000 | 37,715,260 | |
MongoDB, Inc. Class A (a) | 132,000 | 54,250,680 | |
Shopify, Inc. Class A (a) | 93,500 | 6,040,100 | |
Snowflake, Inc. (a) | 220,400 | 38,785,992 | |
Twilio, Inc. Class A (a) | 582,941 | 37,086,706 | |
Wix.com Ltd. (a) | 88,300 | 6,908,592 | |
X Holdings Corp. Class A (c) | 31,890 | 1,234,781 | |
361,503,269 | |||
Semiconductors & Semiconductor Equipment - 4.1% | |||
Advanced Micro Devices, Inc. (a) | 352,371 | 40,138,581 | |
Analog Devices, Inc. | 796,361 | 155,139,086 | |
Intel Corp. | 1,023,400 | 34,222,496 | |
Marvell Technology, Inc. | 338,244 | 20,220,226 | |
Microchip Technology, Inc. | 450,604 | 40,369,612 | |
Micron Technology, Inc. | 1,507,011 | 95,107,464 | |
NVIDIA Corp. | 570,200 | 241,206,004 | |
ON Semiconductor Corp. (a) | 182,500 | 17,260,850 | |
Skyworks Solutions, Inc. | 150,763 | 16,687,956 | |
SolarEdge Technologies, Inc. (a) | 96,400 | 25,936,420 | |
686,288,695 | |||
Software - 12.5% | |||
Adobe, Inc. (a) | 418,349 | 204,568,478 | |
Aspen Technology, Inc. (a) | 60,990 | 10,222,534 | |
Atlassian Corp. PLC (a) | 217,100 | 36,431,551 | |
Autodesk, Inc. (a) | 334,832 | 68,509,976 | |
Blackbaud, Inc. (a) | 223,900 | 15,937,202 | |
Constellation Software, Inc. | 9,990 | 20,698,360 | |
Elastic NV (a) | 420,200 | 26,943,224 | |
Five9, Inc. (a) | 390,400 | 32,188,480 | |
Gen Digital, Inc. | 1,429,210 | 26,511,846 | |
HubSpot, Inc. (a) | 94,304 | 50,178,215 | |
Lumine Group, Inc. | 33,574 | 460,494 | |
Microsoft Corp. | 3,381,759 | 1,151,624,206 | |
New Relic, Inc. (a) | 90,800 | 5,941,952 | |
Palo Alto Networks, Inc. (a) | 220,990 | 56,465,155 | |
PTC, Inc. (a) | 286,557 | 40,777,061 | |
Roper Technologies, Inc. | 28,900 | 13,895,120 | |
Salesforce, Inc. (a) | 938,938 | 198,360,042 | |
Tenable Holdings, Inc. (a) | 962,900 | 41,934,295 | |
Workday, Inc. Class A (a) | 312,189 | 70,520,373 | |
Workiva, Inc. (a) | 152,811 | 15,534,766 | |
2,087,703,330 | |||
Technology Hardware, Storage & Peripherals - 5.9% | |||
Apple, Inc. | 4,995,432 | 968,963,945 | |
Western Digital Corp. (a) | 329,014 | 12,479,501 | |
981,443,446 | |||
TOTAL INFORMATION TECHNOLOGY | 4,195,551,615 | ||
MATERIALS - 2.7% | |||
Chemicals - 1.7% | |||
Air Products & Chemicals, Inc. | 80,789 | 24,198,729 | |
Ashland, Inc. | 71,500 | 6,214,065 | |
Cabot Corp. | 150,000 | 10,033,500 | |
Celanese Corp. Class A | 171,900 | 19,906,020 | |
Chemtrade Logistics Income Fund | 904,680 | 5,593,002 | |
Corteva, Inc. | 430,500 | 24,667,650 | |
Dow, Inc. | 88,900 | 4,734,814 | |
DuPont de Nemours, Inc. | 251,207 | 17,946,228 | |
Eastman Chemical Co. | 31,000 | 2,595,320 | |
Element Solutions, Inc. | 167,900 | 3,223,680 | |
Huntsman Corp. | 112,900 | 3,050,558 | |
Linde PLC | 245,700 | 93,631,356 | |
LyondellBasell Industries NV Class A | 251,700 | 23,113,611 | |
Olin Corp. | 225,084 | 11,567,067 | |
Orion SA | 85,700 | 1,818,554 | |
RPM International, Inc. | 24,600 | 2,207,358 | |
The Chemours Co. LLC | 427,300 | 15,763,097 | |
Tronox Holdings PLC | 772,700 | 9,821,017 | |
Westlake Corp. | 59,800 | 7,144,306 | |
287,229,932 | |||
Construction Materials - 0.2% | |||
Martin Marietta Materials, Inc. | 26,622 | 12,291,111 | |
Vulcan Materials Co. | 56,200 | 12,669,728 | |
24,960,839 | |||
Containers & Packaging - 0.2% | |||
Aptargroup, Inc. | 109,400 | 12,675,084 | |
Avery Dennison Corp. | 43,800 | 7,524,840 | |
Crown Holdings, Inc. | 80,195 | 6,966,540 | |
Greif, Inc. Class A | 152,800 | 10,526,392 | |
37,692,856 | |||
Metals & Mining - 0.6% | |||
Alcoa Corp. | 56,900 | 1,930,617 | |
Commercial Metals Co. | 141,556 | 7,454,339 | |
First Quantum Minerals Ltd. | 955,980 | 22,615,900 | |
Franco-Nevada Corp. | 50,900 | 7,254,523 | |
Freeport-McMoRan, Inc. | 812,200 | 32,488,000 | |
Glencore PLC | 856,200 | 4,854,556 | |
Horizonte Minerals PLC (a) | 1,616,300 | 2,955,889 | |
Ivanhoe Mines Ltd. (a) | 522,100 | 4,768,756 | |
Major Drilling Group International, Inc. (a) | 341,500 | 2,356,150 | |
Reliance Steel & Aluminum Co. | 41,400 | 11,243,826 | |
Steel Dynamics, Inc. | 46,300 | 5,043,459 | |
Wheaton Precious Metals Corp. | 71,600 | 3,096,406 | |
106,062,421 | |||
TOTAL MATERIALS | 455,946,048 | ||
REAL ESTATE - 2.9% | |||
Equity Real Estate Investment Trusts (REITs) - 2.7% | |||
Alexandria Real Estate Equities, Inc. | 95,800 | 10,872,342 | |
American Tower Corp. | 120,704 | 23,409,334 | |
Crown Castle International Corp. | 405,700 | 46,225,458 | |
CubeSmart | 866,815 | 38,711,958 | |
Digital Realty Trust, Inc. | 118,000 | 13,436,660 | |
Equinix, Inc. | 55,800 | 43,743,852 | |
Equity Lifestyle Properties, Inc. | 240,000 | 16,053,600 | |
Essex Property Trust, Inc. | 84,059 | 19,695,024 | |
Four Corners Property Trust, Inc. | 557,503 | 14,160,576 | |
Invitation Homes, Inc. | 435,151 | 14,969,194 | |
Lamar Advertising Co. Class A | 147,400 | 14,629,450 | |
Mid-America Apartment Communities, Inc. | 146,800 | 22,293,048 | |
Omega Healthcare Investors, Inc. | 467,300 | 14,341,437 | |
Prologis (REIT), Inc. | 484,451 | 59,408,226 | |
Ryman Hospitality Properties, Inc. | 149,900 | 13,928,708 | |
SITE Centers Corp. | 766,600 | 10,134,452 | |
Spirit Realty Capital, Inc. | 219,300 | 8,636,034 | |
Tanger Factory Outlet Centers, Inc. | 68,100 | 1,502,967 | |
Terreno Realty Corp. | 203,500 | 12,230,350 | |
UDR, Inc. | 233,300 | 10,022,568 | |
Urban Edge Properties | 627,600 | 9,683,868 | |
Ventas, Inc. | 627,000 | 29,638,290 | |
VICI Properties, Inc. | 181,700 | 5,710,831 | |
453,438,227 | |||
Real Estate Management & Development - 0.2% | |||
CBRE Group, Inc. (a) | 245,300 | 19,798,163 | |
Doma Holdings, Inc. Class A (a)(b) | 169,561 | 837,631 | |
Jones Lang LaSalle, Inc. (a) | 38,600 | 6,013,880 | |
26,649,674 | |||
TOTAL REAL ESTATE | 480,087,901 | ||
UTILITIES - 2.5% | |||
Electric Utilities - 1.6% | |||
Constellation Energy Corp. | 362,181 | 33,157,671 | |
Duke Energy Corp. | 92,800 | 8,327,872 | |
Edison International | 339,882 | 23,604,805 | |
Exelon Corp. | 105,895 | 4,314,162 | |
FirstEnergy Corp. | 296,479 | 11,527,104 | |
NextEra Energy, Inc. | 860,417 | 63,842,941 | |
NRG Energy, Inc. | 175,100 | 6,546,989 | |
PG&E Corp. (a) | 2,084,506 | 36,020,264 | |
Pinnacle West Capital Corp. | 112,900 | 9,196,834 | |
PPL Corp. | 443,600 | 11,737,656 | |
Southern Co. | 841,955 | 59,147,339 | |
267,423,637 | |||
Independent Power and Renewable Electricity Producers - 0.2% | |||
Clearway Energy, Inc. Class A | 44,888 | 1,211,976 | |
Energy Harbor Corp. (a) | 72,800 | 5,623,800 | |
NextEra Energy Partners LP | 81,998 | 4,808,363 | |
Sunnova Energy International, Inc. (a)(b) | 112,700 | 2,063,537 | |
The AES Corp. | 266,900 | 5,532,837 | |
Vistra Corp. | 566,478 | 14,870,048 | |
34,110,561 | |||
Multi-Utilities - 0.6% | |||
Dominion Energy, Inc. | 329,313 | 17,055,120 | |
DTE Energy Co. | 128,600 | 14,148,572 | |
NiSource, Inc. | 642,002 | 17,558,755 | |
Public Service Enterprise Group, Inc. | 321,436 | 20,125,108 | |
Sempra Energy | 214,603 | 31,244,051 | |
100,131,606 | |||
Water Utilities - 0.1% | |||
American Water Works Co., Inc. | 107,000 | 15,274,250 | |
TOTAL UTILITIES | 416,940,054 | ||
TOTAL COMMON STOCKS (Cost $10,909,242,589) | 16,433,061,272 | ||
Preferred Stocks - 0.4% | |||
Shares | Value ($) | ||
Convertible Preferred Stocks - 0.3% | |||
COMMUNICATION SERVICES - 0.1% | |||
Interactive Media & Services - 0.1% | |||
Reddit, Inc. Series F (a)(c)(e) | 236,672 | 8,186,484 | |
FINANCIALS - 0.0% | |||
Financial Services - 0.0% | |||
Circle Internet Financial Ltd. Series F (a)(c)(e) | 160,054 | 3,849,299 | |
Saluda Medical, Inc. Series E (c)(e) | 301,188 | 2,424,563 | |
6,273,862 | |||
HEALTH CARE - 0.2% | |||
Biotechnology - 0.1% | |||
Asimov, Inc. Series B (a)(c)(e) | 35,044 | 1,695,779 | |
Caris Life Sciences, Inc. Series D (a)(c)(e) | 1,077,331 | 6,033,054 | |
Cleerly, Inc. Series C (c)(e) | 411,426 | 4,788,999 | |
Element Biosciences, Inc. Series C (a)(c)(e) | 195,016 | 3,118,306 | |
ElevateBio LLC Series C (a)(c)(e) | 626,000 | 2,654,240 | |
Inscripta, Inc. Series E (a)(c)(e) | 423,474 | 1,791,295 | |
20,081,673 | |||
Health Care Providers & Services - 0.0% | |||
dMed Biopharmaceutical Co. Ltd. Series C (a)(c)(e) | 416,172 | 3,258,627 | |
Health Care Technology - 0.1% | |||
Aledade, Inc.: | |||
Series B1(a)(c)(e) | 67,586 | 3,387,410 | |
Series E1(a)(c)(e) | 14,822 | 742,879 | |
Omada Health, Inc. Series E (a)(c)(e) | 597,550 | 1,971,915 | |
Wugen, Inc. Series B (a)(c)(e) | 155,150 | 775,750 | |
6,877,954 | |||
Pharmaceuticals - 0.0% | |||
Aristea Therapeutics, Inc. Series B (a)(c)(e) | 391,809 | 2,158,868 | |
Galvanize Therapeutics Series B (a)(c)(e) | 1,112,588 | 1,802,393 | |
3,961,261 | |||
TOTAL HEALTH CARE | 34,179,515 | ||
TOTAL CONVERTIBLE PREFERRED STOCKS | 48,639,861 | ||
Nonconvertible Preferred Stocks - 0.1% | |||
FINANCIALS - 0.1% | |||
Financial Services - 0.1% | |||
Circle Internet Financial Ltd. Series E (a)(c)(e) | 388,096 | 9,333,709 | |
Thriveworks TopCo LLC Series B (a)(c)(e)(f) | 141,317 | 2,046,270 | |
11,379,979 | |||
TOTAL PREFERRED STOCKS (Cost $79,511,579) | 60,019,840 | ||
Convertible Bonds - 0.1% | |||
Principal Amount (g) | Value ($) | ||
FINANCIALS - 0.1% | |||
Financial Services - 0.1% | |||
Affirm Holdings, Inc. 0% 11/15/26 (Cost $6,892,837) | 10,273,000 | 7,582,501 | |
U.S. Treasury Obligations - 0.0% | |||
Principal Amount (g) | Value ($) | ||
U.S. Treasury Bills, yield at date of purchase 5.11% to 5.2% 7/27/23 to 9/14/23 (h) (Cost $3,889,047) | 3,920,000 | 3,889,729 | |
Money Market Funds - 1.6% | |||
Shares | Value ($) | ||
Fidelity Cash Central Fund 5.14% (i) | 204,998,854 | 205,039,854 | |
Fidelity Securities Lending Cash Central Fund 5.14% (i)(j) | 65,699,168 | 65,705,738 | |
TOTAL MONEY MARKET FUNDS (Cost $270,745,592) | 270,745,592 | ||
TOTAL INVESTMENT IN SECURITIES - 100.5% (Cost $11,270,281,644) | 16,775,298,934 |
NET OTHER ASSETS (LIABILITIES) - (0.5)% | (75,842,028) |
NET ASSETS - 100.0% | 16,699,456,906 |
Futures Contracts | |||||
Number of contracts | Expiration Date | Notional Amount ($) | Value ($) | Unrealized Appreciation/ (Depreciation) ($) | |
Purchased | |||||
Equity Index Contracts | |||||
CME E-mini S&P 500 Index Contracts (United States) | 169 | Sep 2023 | 37,925,713 | 661,416 | 661,416 |
The notional amount of futures purchased as a percentage of Net Assets is 0.2% |
(a) | Non-income producing |
(b) | Security or a portion of the security is on loan at period end. |
(c) | Level 3 security |
(d) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $12,028,840 or 0.1% of net assets. |
(e) | Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $106,290,257 or 0.6% of net assets. |
(f) | Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes. |
(g) | Amount is stated in United States dollars unless otherwise noted. |
(h) | Security or a portion of the security was pledged to cover margin requirements for futures contracts. At period end, the value of securities pledged amounted to $2,003,560. |
(i) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements, which are not covered by the Fund's Report of Independent Registered Public Accounting Firm, are available on the SEC's website or upon request. |
(j) | Investment made with cash collateral received from securities on loan. |
Additional information on each restricted holding is as follows: | ||
Security | Acquisition Date | Acquisition Cost ($) |
Aledade, Inc. Series B1 | 5/07/21 | 2,587,915 |
Aledade, Inc. Series E1 | 5/20/22 | 738,349 |
Ant International Co. Ltd. Class C | 5/16/18 | 21,348,159 |
Aristea Therapeutics, Inc. Series B | 10/06/20 | 2,160,317 |
Asimov, Inc. Series B | 10/29/21 | 3,247,902 |
Caris Life Sciences, Inc. | 10/06/22 | 1,271,553 |
Caris Life Sciences, Inc. Series D | 5/11/21 | 8,726,381 |
Circle Internet Financial Ltd. Series E | 5/11/21 | 6,298,800 |
Circle Internet Financial Ltd. Series F | 5/09/22 | 6,744,676 |
Cleerly, Inc. Series C | 7/08/22 | 4,846,845 |
dMed Biopharmaceutical Co. Ltd. Series C | 12/01/20 | 5,910,953 |
Element Biosciences, Inc. Series C | 6/21/21 | 4,008,885 |
ElevateBio LLC Series C | 3/09/21 | 2,626,070 |
Evolent Health, Inc. | 3/28/23 | 14,500,000 |
Galvanize Therapeutics Series B | 3/29/22 | 1,926,207 |
Inscripta, Inc. Series E | 3/30/21 | 3,739,275 |
Omada Health, Inc. Series E | 12/22/21 | 3,582,432 |
Reddit, Inc. Series F | 8/11/21 | 14,625,004 |
Saluda Medical, Inc. Series E | 4/06/23 | 2,431,732 |
Starling Bank Ltd. Series D | 6/18/21 | 8,257,037 |
The Beauty Health Co. | 12/08/20 | 6,000,000 |
Thriveworks TopCo LLC Series B | 7/23/21 - 2/25/22 | 4,060,362 |
Wugen, Inc. Series B | 7/09/21 | 1,203,173 |
Affiliate | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | % ownership, end of period |
Fidelity Cash Central Fund 5.14% | 149,637,573 | 4,076,682,508 | 4,021,280,227 | 5,760,865 | - | - | 205,039,854 | 0.5% |
Fidelity Securities Lending Cash Central Fund 5.14% | 130,631,814 | 761,978,874 | 826,904,950 | 635,260 | - | - | 65,705,738 | 0.2% |
Total | 280,269,387 | 4,838,661,382 | 4,848,185,177 | 6,396,125 | - | - | 270,745,592 | |
Valuation Inputs at Reporting Date: | ||||
Description | Total ($) | Level 1 ($) | Level 2 ($) | Level 3 ($) |
Investments in Securities: | ||||
Equities: | ||||
Communication Services | 1,408,131,663 | 1,399,945,179 | - | 8,186,484 |
Consumer Discretionary | 1,749,883,238 | 1,726,989,409 | 22,893,829 | - |
Consumer Staples | 1,117,749,397 | 1,107,749,129 | 10,000,266 | 2 |
Energy | 695,891,331 | 695,891,331 | - | - |
Financials | 2,092,358,799 | 1,937,107,470 | 111,059,884 | 44,191,445 |
Health Care | 2,172,489,134 | 2,047,271,575 | 89,241,462 | 35,976,097 |
Industrials | 1,708,051,932 | 1,708,051,932 | - | - |
Information Technology | 4,195,551,615 | 4,137,283,638 | 57,033,196 | 1,234,781 |
Materials | 455,946,048 | 451,091,492 | 4,854,556 | - |
Real Estate | 480,087,901 | 480,087,901 | - | - |
Utilities | 416,940,054 | 416,940,054 | - | - |
Corporate Bonds | 7,582,501 | - | 7,582,501 | - |
U.S. Government and Government Agency Obligations | 3,889,729 | - | 3,889,729 | - |
Money Market Funds | 270,745,592 | 270,745,592 | - | - |
Total Investments in Securities: | 16,775,298,934 | 16,379,154,702 | 306,555,423 | 89,588,809 |
Derivative Instruments: | ||||
Assets | ||||
Futures Contracts | 661,416 | 661,416 | - | - |
Total Assets | 661,416 | 661,416 | - | - |
Total Derivative Instruments: | 661,416 | 661,416 | - | - |
Primary Risk Exposure / Derivative Type | Value | |
Asset ($) | Liability ($) | |
Equity Risk | ||
Futures Contracts (a) | 661,416 | 0 |
Total Equity Risk | 661,416 | 0 |
Total Value of Derivatives | 661,416 | 0 |
Statement of Assets and Liabilities | ||||
June 30, 2023 | ||||
Assets | ||||
Investment in securities, at value (including securities loaned of $63,339,233) - See accompanying schedule: | ||||
Unaffiliated issuers (cost $10,999,536,052) | $ | 16,504,553,342 | ||
Fidelity Central Funds (cost $270,745,592) | 270,745,592 | |||
Total Investment in Securities (cost $11,270,281,644) | $ | 16,775,298,934 | ||
Cash | 410,038 | |||
Foreign currency held at value (cost $1,598,493) | 1,594,191 | |||
Receivable for investments sold | 26,028,057 | |||
Receivable for fund shares sold | 24,956 | |||
Dividends receivable | 11,437,816 | |||
Distributions receivable from Fidelity Central Funds | 861,057 | |||
Receivable for daily variation margin on futures contracts | 443,625 | |||
Other receivables | 250,289 | |||
Total assets | 16,816,348,963 | |||
Liabilities | ||||
Payable for investments purchased | $ | 36,736,977 | ||
Payable for fund shares redeemed | 14,422,953 | |||
Other payables and accrued expenses | 26,389 | |||
Collateral on securities loaned | 65,705,738 | |||
Total Liabilities | 116,892,057 | |||
Net Assets | $ | 16,699,456,906 | ||
Net Assets consist of: | ||||
Paid in capital | $ | 10,726,154,243 | ||
Total accumulated earnings (loss) | 5,973,302,663 | |||
Net Assets | $ | 16,699,456,906 | ||
Net Asset Value , offering price and redemption price per share ($16,699,456,906 ÷ 138,878,542 shares) | $ | 120.25 |
Statement of Operations | ||||
Year ended June 30, 2023 | ||||
Investment Income | ||||
Dividends | $ | 210,369,461 | ||
Interest | 982,441 | |||
Income from Fidelity Central Funds (including $635,260 from security lending) | 6,396,125 | |||
Total Income | 217,748,027 | |||
Expenses | ||||
Custodian fees and expenses | $ | 103,514 | ||
Independent trustees' fees and expenses | 84,546 | |||
Interest | 45,346 | |||
Total Expenses | 233,406 | |||
Net Investment income (loss) | 217,514,621 | |||
Realized and Unrealized Gain (Loss) | ||||
Net realized gain (loss) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | 695,098,298 | |||
Foreign currency transactions | (264,985) | |||
Futures contracts | 5,617,602 | |||
Total net realized gain (loss) | 700,450,915 | |||
Change in net unrealized appreciation (depreciation) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | 2,199,332,881 | |||
Assets and liabilities in foreign currencies | 44,651 | |||
Futures contracts | 666,082 | |||
Total change in net unrealized appreciation (depreciation) | 2,200,043,614 | |||
Net gain (loss) | 2,900,494,529 | |||
Net increase (decrease) in net assets resulting from operations | $ | 3,118,009,150 |
Statement of Changes in Net Assets | ||||
Year ended June 30, 2023 | Year ended June 30, 2022 | |||
Increase (Decrease) in Net Assets | ||||
Operations | ||||
Net investment income (loss) | $ | 217,514,621 | $ | 259,201,447 |
Net realized gain (loss) | 700,450,915 | 4,400,424,206 | ||
Change in net unrealized appreciation (depreciation) | 2,200,043,614 | (7,653,205,554) | ||
Net increase (decrease) in net assets resulting from operations | 3,118,009,150 | (2,993,579,901) | ||
Distributions to shareholders | (445,588,465) | (1,982,604,210) | ||
Affiliated share transactions | ||||
Proceeds from sales of shares | 428,911,043 | 1,480,601,338 | ||
Reinvestment of distributions | 445,588,465 | 1,982,604,210 | ||
Cost of shares redeemed | (3,480,179,601) | (10,094,925,893) | ||
Net increase (decrease) in net assets resulting from share transactions | (2,605,680,093) | (6,631,720,345) | ||
Total increase (decrease) in net assets | 66,740,592 | (11,607,904,456) | ||
Net Assets | ||||
Beginning of period | 16,632,716,314 | 28,240,620,770 | ||
End of period | $ | 16,699,456,906 | $ | 16,632,716,314 |
Other Information | ||||
Shares | ||||
Sold | 3,996,159 | 11,218,721 | ||
Issued in reinvestment of distributions | 4,154,208 | 15,351,739 | ||
Redeemed | (31,903,995) | (76,700,915) | ||
Net increase (decrease) | (23,753,628) | (50,130,455) | ||
Fidelity® U.S. Equity Central Fund |
Years ended June 30, | 2023 | 2022 | 2021 A | |||
Selected Per-Share Data | ||||||
Net asset value, beginning of period | $ | 102.27 | $ | 132.73 | $ | 100.00 |
Income from Investment Operations | ||||||
Net investment income (loss) B,C | 1.47 | 1.41 | 1.05 | |||
Net realized and unrealized gain (loss) | 19.57 | (19.85) | 33.21 | |||
Total from investment operations | 21.04 | (18.44) | 34.26 | |||
Distributions from net investment income | (1.52) | (1.38) | (.87) | |||
Distributions from net realized gain | (1.54) | (10.64) | (.66) | |||
Total distributions | (3.06) | (12.02) | (1.53) | |||
Net asset value, end of period | $ | 120.25 | $ | 102.27 | $ | 132.73 |
Total Return D,E | 20.95% | (15.73)% | 34.47% | |||
Ratios to Average Net Assets C,F,G | ||||||
Expenses before reductions H | -% | -% | -% I | |||
Expenses net of fee waivers, if any H | -% | -% | -% I | |||
Expenses net of all reductions H | -% | -% | -% I | |||
Net investment income (loss) | 1.34% | 1.10% | 1.12% I | |||
Supplemental Data | ||||||
Net assets, end of period (000 omitted) | $ | 16,699,457 | $ | 16,632,716 | $ | 28,240,621 |
Portfolio turnover rate J | 31% | 34% K | 47% I,L |
Fidelity Central Fund | Investment Manager | Investment Objective | Investment Practices | Expense Ratio A |
Fidelity Money Market Central Funds | Fidelity Management & Research Company LLC (FMR) | Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity. | Short-term Investments | Less than .005% |
Gross unrealized appreciation | $6,035,442,237 |
Gross unrealized depreciation | (590,666,394) |
Net unrealized appreciation (depreciation) | $5,444,775,843 |
Tax Cost | $11,330,523,091 |
Undistributed ordinary income | $25,291,409 |
Undistributed long-term capital gain | $502,825,585 |
Net unrealized appreciation (depreciation) on securities and other investments | $5,445,185,669 |
June 30, 2023 | June 30, 2022 | |
Ordinary Income | $222,295,629 | $470,361,792 |
Long-term Capital Gains | 223,292,836 | 1,512,242,418 |
Total | $445,588,465 | $1,982,604,210 |
$ Amount | % of Net Assets | |
Fidelity U.S. Equity Central Fund | 2,046,270 | .01 |
Equity Risk | Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment. |
Purchases ($) | Sales ($) | |
Fidelity U.S. Equity Central Fund | 5,051,851,106 | 7,894,759,005 |
Amount | |
Fidelity U.S. Equity Central Fund | $110,267 |
Borrower or Lender | Average Loan Balance | Weighted Average Interest Rate | Interest Expense | |
Fidelity U.S. Equity Central Fund | Borrower | $45,865,917 | 2.97% | $45,346 |
Purchases ($) | Sales ($) | Realized Gain (Loss) ($) | |
Fidelity U.S. Equity Central Fund | 318,313,449 | 561,173,993 | 57,380,060 |
Shares | Total net realized gain or loss ($) | Total Proceeds ($) | |
Fidelity U.S. Equity Central Fund | 42,998,101 | 3,072,585,365 | 6,008,984,643 |
Total Security Lending Fees Paid to NFS | Security Lending Income From Securities Loaned to NFS | Value of Securities Loaned to NFS at Period End | |
Fidelity U.S. Equity Central Fund | $65,491 | $45,723 | $1,092,900 |
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (January 1, 2023 to June 30, 2023). |
Annualized Expense Ratio- A | Beginning Account Value January 1, 2023 | Ending Account Value June 30, 2023 | Expenses Paid During Period- C January 1, 2023 to June 30, 2023 | |||||||
Fidelity® U.S. Equity Central Fund | 0.0016% | |||||||||
Actual | $ 1,000 | $ 1,169.30 | $ .01 | |||||||
Hypothetical- B | $ 1,000 | $ 1,024.79 | $ .01 | |||||||
- Highly liquid investments - cash or convertible to cash within three business days or less
- Moderately liquid investments - convertible to cash in three to seven calendar days
- Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
- Illiquid investments - cannot be sold or disposed of within seven calendar days
Item 2.
Code of Ethics
As of the end of the period, June 30, 2023, Fidelity Central Investment Portfolios LLC (the trust) has adopted a code of ethics, as defined in Item 2 of Form N-CSR, that applies to its President and Treasurer and its Chief Financial Officer. A copy of the code of ethics is filed as an exhibit to this Form N-CSR.
Item 3.
Audit Committee Financial Expert
The Board of Trustees of the trust has determined that Donald F. Donahue is an audit committee financial expert, as defined in Item 3 of Form N-CSR. Mr. Donahue is independent for purposes of Item 3 of Form N-CSR.
Item 4.
Principal Accountant Fees and Services
Fees and Services
The following table presents fees billed by Deloitte & Touche LLP, the member firms of Deloitte Touche Tohmatsu, and their respective affiliates (collectively, “Deloitte Entities”) in each of the last two fiscal years for services rendered to Fidelity U.S. Equity Central Fund (the “Fund”):
Services Billed by Deloitte Entities
June 30, 2023 FeesA
Audit Fees | Audit-Related Fees | Tax Fees | All Other Fees | |
Fidelity U.S. Equity Central Fund | $50,000 | $- | $8,000 | $1,100 |
June 30, 2022 FeesA
Audit Fees | Audit-Related Fees | Tax Fees | All Other Fees | |
Fidelity U.S. Equity Central Fund | $46,700 | $- | $9,900 | $1,000 |
A Amounts may reflect rounding.
The following table(s) present(s) fees billed by Deloitte Entities that were required to be approved by the Audit Committee for services that relate directly to the operations and financial reporting of the Fund(s) and that are rendered on behalf of Fidelity Management
& Research Company LLC ("FMR") and entities controlling, controlled by, or under common control with FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser) that provide ongoing services to the Fund(s) (“Fund Service Providers”):
Services Billed by Deloitte Entities
June 30, 2023A | June 30, 2022 A | |
Audit-Related Fees | $- | $- |
Tax Fees | $- | $- |
All Other Fees | $- | $- |
A Amounts may reflect rounding.
“Audit-Related Fees” represent fees billed for assurance and related services that are reasonably related to the performance of the fund audit or the review of the fund's financial statements and that are not reported under Audit Fees.
“Tax Fees” represent fees billed for tax compliance, tax advice or tax planning that relate directly to the operations and financial reporting of the fund.
“All Other Fees” represent fees billed for services provided to the fund or Fund Service Provider, a significant portion of which are assurance related, that relate directly to the operations and financial reporting of the fund, excluding those services that are reported under Audit Fees, Audit-Related Fees or Tax Fees.
Assurance services must be performed by an independent public accountant.
* * *
The aggregate non-audit fees billed by Deloitte Entities for services rendered to the Fund(s), FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any Fund Service Provider for each of the last two fiscal years of the Fund(s) are as follows:
Billed By | June 30, 2023A | June 30, 2022A |
Deloitte Entities | $251,700 | $468,500 |
A Amounts may reflect rounding.
The trust's Audit Committee has considered non-audit services that were not pre-approved that were provided by Deloitte Entities to Fund Service Providers to be compatible with maintaining the independence of Deloitte Entities in its(their) audit of the Fund(s), taking into account representations from Deloitte Entities, in accordance with Public Company Accounting Oversight Board rules, regarding its independence from the Fund(s) and its(their) related entities and FMR’s review of the appropriateness and permissibility under applicable law of such non-audit services prior to their provision to the Fund(s) Service Providers.
Audit Committee Pre-Approval Policies and Procedures
The trust’s Audit Committee must pre-approve all audit and non-audit services provided by a fund’s independent registered public accounting firm relating to the operations or financial reporting of the fund. Prior to the commencement of any audit or non-audit services to a fund, the Audit Committee reviews the services to determine whether they are appropriate and permissible under applicable law.
The Audit Committee has adopted policies and procedures to, among other purposes, provide a framework for the Committee’s consideration of non-audit services by the audit firms that audit the Fidelity funds. The policies and procedures require that any non-audit service provided by a fund audit firm to a Fidelity fund and any non-audit service provided by a fund auditor to a Fund Service Provider that relates directly to the operations and financial reporting of a Fidelity fund (“Covered Service”) are subject to approval by the Audit Committee before such service is provided.
All Covered Services must be approved in advance of provision of the service either: (i) by formal resolution of the Audit Committee, or (ii) by oral or written approval of the service by the Chair of the Audit Committee (or if the Chair is unavailable, such other member of the Audit Committee as may be designated by the Chair to act in the Chair’s absence). The approval contemplated by (ii) above is permitted where the Treasurer determines that action on such an engagement is necessary before the next meeting of the Audit Committee.
Non-audit services provided by a fund audit firm to a Fund Service Provider that do not relate directly to the operations and financial reporting of a Fidelity fund are reported to the Audit Committee periodically.
Non-Audit Services Approved Pursuant to Rule 2-01(c)(7)(i)(C) and (ii) of Regulation S-X (“De Minimis Exception”)
There were no non-audit services approved or required to be approved by the Audit Committee pursuant to the De Minimis Exception during the Fund’s(s’) last two fiscal years relating to services provided to (i) the Fund(s) or (ii) any Fund Service Provider that relate directly to the operations and financial reporting of the Fund(s).
Item 5.
Audit Committee of Listed Registrants
Not applicable.
Item 6.
Investments
(a)
Not applicable.
(b)
Not applicable.
Item 7.
Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies
Not applicable.
Item 8.
Portfolio Managers of Closed-End Management Investment Companies
Not applicable.
Item 9.
Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers
Not applicable.
Item 10.
Submission of Matters to a Vote of Security Holders
There were no material changes to the procedures by which shareholders may recommend nominees to the trust’s Board of Trustees.
Item 11.
Controls and Procedures
(a)(i) The President and Treasurer and the Chief Financial Officer have concluded that the trust’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.
(a)(ii) There was no change in the trust’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the trust’s internal control over financial reporting.
Item 12.
Disclosure of Securities Lending Activities for Closed-End Management
Investment Companies
Not applicable.
Item 13.
Exhibits
(a) | (1) | Code of Ethics pursuant to Item 2 of Form N-CSR is filed and attached hereto as EX-99.CODE ETH. |
(a) | (2) | |
(a) | (3) | Not applicable. |
(b) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Fidelity Central Investment Portfolios LLC
By: | /s/Stacie M. Smith |
Stacie M. Smith | |
President and Treasurer | |
Date: | August 22, 2023 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/Stacie M. Smith |
Stacie M. Smith | |
President and Treasurer | |
Date: | August 22, 2023 |
By: | /s/John J. Burke III |
John J. Burke III | |
Chief Financial Officer | |
Date: | August 22, 2023 |